John Spiliotis, Odysseas Zoras. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, HumanizedAntineoplastic Agents/administration & dosageCetuximabChemotherapy, AdjuvantColorectal Neoplasms/drug therapyColorectal Neoplasms/pathologyColorectal Neoplasms/surgeryEpidermal Growth Factor/antagonists & inhibitorsHepatectomyHumansLiver/drug effectsLiver/pathologyLiver Neoplasms/drug therapyLiver Neoplasms/secondaryLiver Neoplasms/surgeryNeoadjuvant Therapy
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic AgentsEpidermal Growth FactorCetuximab
Year: 2011 PMID: 21184075 DOI: 10.1007/s00268-010-0915-4
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352